Identification of novel serum biomarkers in child nephroblastoma using proteomics technology

Molecular Biology Reports

Volumn 38, Issue 1, 2011, Pages 631-638

  Zhang, Qian ^a   Wang, Jiaxiang ^a   Dong, Rui ^a   Yang, Shaobo ^a   Zheng, Shu ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Apolipoprotein C I; Haptoglobin; MALDI TOF MS; Nephroblastoma; SELDI TOF MS

Indexed keywords

APOLIPOPROTEIN C1; BIOLOGICAL MARKER; HAPTOGLOBIN;

ARTICLE; CANCER STAGING; CHILD; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; DATABASES, PROTEIN; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDE MAPPING; PROTEOMICS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 78651107882     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0149-4     Document Type: Article

References (28)

1. DR Hargrave, et al. 2001 Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI) Br J Haematol 112 2 293 299 1:STN:280:DC%2BD3M7lvValsQ%3D%3D 10.1046/j.1365-2141.2001.02543.x 11167821 (Pubitemid 32183469)
2. OB Eden, et al. 2000 Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party Leukemia 14 12 2307 2320 1:CAS:528:DC%2BD3MXmtVamsA%3D%3D 10.1038/sj.leu.2401962 11187922 (Pubitemid 32042271)
3. McGregor LM et al (2007) Pediatric cancers in the new millennium: dramatic progress, new challenges. Oncology (Williston Park) 21(7): 809-820; discussion 820, 823-824
4. JE Rubnitz, et al. 2004 Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience Cancer 101 7 1677 1684 10.1002/cncr.20532 15378506 (Pubitemid 39318917)
5. JE Lawn S Cousens J Zupan 2005 4 million neonatal deaths: when? Where? Why? Lancet 365 9462 891 900 10.1016/S0140-6736(05)71048-5 15752534 (Pubitemid 40332168)
6. D Miniati, et al. 2008 Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children J Pediatr Surg 43 7 1301 1307 10.1016/j.jpedsurg.2008.02.077 18639686 (Pubitemid 351970556)
7. NM Lindor, et al. 2008 Concise handbook of familial cancer susceptibility syndromes-second edition J Natl Cancer Inst Monogr 38 1 93 18559331
8. PF Ehrlich 2007 Wilms tumor: progress and considerations for the surgeon Surg Oncol 16 3 157 171 1:STN:280:DC%2BD2snnsVGnsA%3D%3D 10.1016/j.suronc.2007. 07.001 17689073
9. LR Medeiros, et al. 2009 Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review Eur J Obstet Gynecol Reprod Biol 142 2 99 105 1:CAS:528:DC%2BD1MXhs1ektL0%3D 18995946
10. KH Tsui, et al. 1997 Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography Changgeng Yi Xue Za Zhi 20 1 23 28 1:STN:280: DyaK2szitFyqtQ%3D%3D 9178589
11. S Velaiutham, et al. 2008 Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer? Asian Pac J Cancer Prev 9 3 445 448 1:STN:280:DC%2BD1cjitleiuw%3D%3D 18990019
12. L Zhong DL Taylor RJ Whittington 2010 Proteomic profiling of ovine serum by SELDI-TOF MS: optimisation, reproducibility and feasibility of biomarker discovery using routinely collected samples Comp Immunol Microbiol Infect Dis 33 1 47 63 10.1016/j.cimid.2008.07.009 18775566
13. J Wang, et al. 2008 Proteomic studies of early-stage and advanced ovarian cancer patients Gynecol Oncol 111 1 111 119 1:CAS:528:DC%2BD1cXhtFOgsr7E 10.1016/j.ygyno.2008.06.031 18703221
14. M Hong, et al. 2009 The potential biomarkers for thromboembolism detected by SELDI-TOF-MS Thromb Res 123 3 556 564 1:CAS:528:DC%2BD1cXhsFClsL%2FO 10.1016/j.thromres.2008.05.019 18620739
15. HL Huang, et al. 2006 Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays Electrophoresis 27 8 1641 1650 1:CAS:528: DC%2BD28XkslOks78%3D 10.1002/elps.200500857 16550499
16. G Song G Ouyang S Bao 2005 The activation of Akt/PKB signaling pathway and cell survival J Cell Mol Med 9 1 59 71 1:CAS:528:DC%2BD2MXlt1eqtLo%3D 10.1111/j.1582-4934.2005.tb00337.x 15784165
17. GA Turner 1995 Haptoglobin. A potential reporter molecule for glycosylation changes in disease Adv Exp Med Biol 376 231 238 1:CAS:528:DyaK28XisFyktbc%3D 8597253
18. S Marinkovic H Baumann 1990 Structure, hormonal regulation, and identification of the interleukin-6- and dexamethasone-responsive element of the rat haptoglobin gene Mol Cell Biol 10 4 1573 1583 1:CAS:528:DyaK3cXltFSiur0%3D 2320005
19. MR Langlois JR Delanghe 1996 Biological and clinical significance of haptoglobin polymorphism in humans Clin Chem 42 10 1589 1600 1:CAS:528:DyaK28Xmt1eqs70%3D 8855140
20. J Wassell 2000 Haptoglobin: function and polymorphism Clin Lab 46 11-12 547 552 1:CAS:528:DC%2BD3cXos1Ors7s%3D 11109501
21. H Van Vlierberghe M Langlois J Delanghe 2004 Haptoglobin polymorphisms and iron homeostasis in health and in disease Clin Chim Acta 345 1-2 35 42 10.1016/j.cccn.2004.03.016 15193975 (Pubitemid 38749169)
22. M Melamed-Frank, et al. 2001 Structure-function analysis of the antioxidant properties of haptoglobin Blood 98 13 3693 3698 1:CAS:528: DC%2BD3MXptFOjt7Y%3D 10.1182/blood.V98.13.3693 11739174
23. Q He SQ Zhang YL Chu, et al. 2009 The correlations between HPV16 infection and expressions of c-erbB-2 and bcl-2 in breast carcinoma Mol Biol Rep 36 4 807 812 1:CAS:528:DC%2BD1MXisFSkt7s%3D 10.1007/s11033-008-9249-9 18427947
24. M Nakano, et al. 2008 Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers Int J Cancer 122 10 2301 2309 1:CAS:528:DC%2BD1cXkslyntrg%3D 10.1002/ijc.23364 18214858 (Pubitemid 351542335)
25. LF Hoagland 4th, et al. 2007 Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer Cancer 110 10 2260 2268 1:CAS:528:DC%2BD2sXhsVWrtb3F 10.1002/cncr.23049 17918261 (Pubitemid 350100749)
26. H Liu T Zhang B Wu J Huang Y Zhou, et al. 2009 Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells Mol Biol Rep 36 8 2099 2109 1:CAS:528: DC%2BD1MXht1yrs7fK 10.1007/s11033-008-9422-1 19107575
27. T Fujimura, et al. 2008 Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects Int J Cancer 122 1 39 49 1:CAS:528:DC%2BD2sXhsVSgtb%2FL 10.1002/ijc.22958 17803183 (Pubitemid 350209976)
28. C Zhao, et al. 2007 Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer Neoplasia 9 1 1 7 1:CAS:528:DC%2BD2sXhvFCht7s%3D 10.1593/neo.06619 17325738 (Pubitemid 46203929)